| 
			  
			
			
 
  
			25 May 
			2020  
			from
			
			Sky Website
 
 
 
  Professor 
			
			Adrian Hill,
 
			
			director of Oxford University's  
			Jenner 
			Institute 
			  
			  
			  
			Professor Adrian 
			Hill  
			describes the 
			efforts to create  
			a vaccine as a 
			"race against 
			the virus disappearing,  
			and against 
			time". 
			
 
 There is only a 50% chance of the Oxford Coronavirus vaccine working 
			because cases in the UK are declining so fast, one of the scientists 
			behind it has warned.
 
 The University of Oxford's Jenner Institute and the Oxford Vaccine 
			Group began developing a 
			
			COVID-19 vaccine in January using a virus 
			taken from chimpanzees.
 
 But with the number of UK Coronavirus cases dropping every day, 
			there may not be enough people to test it on, according to the 
			institute's director Professor Adrian Hill.
 
 He told
			
			The Sunday Telegraph (and the
			
			Mail on Line):
 
				
				"It's a race against 
				the virus disappearing, and against time. We said earlier in the 
				year that there was an 80% chance of developing an effective 
				vaccine by September.
 "But at the moment, there's a 50% chance that we get no result 
				at all. We're in the bizarre position of wanting COVID to stay, 
				at least for a little while."
 
			On Saturday, 282 people 
			were reported to have died of the virus in the UK across hospitals, 
			care homes and the community.
 The figure has fallen dramatically since the peak of Britain's 
			outbreak, when almost 1,000 people were dying every day in hospitals 
			alone.
 
 Trials of the vaccine - officially known as 
			
			ChAdOx1 nCoV-19 
			(pronounced Chaddox One) - began with an initial phase of testing on 
			160 healthy volunteers between the ages of 18 and 55 to see if it 
			could effectively fight off the virus.
 
 The study is set to progress to
			
			a second and third phase, which 
			will involve testing up to 10,260 people and expanding the age of 
			participants to include children and the elderly.
 
 But if not enough people are able to catch the virus, scientists 
			will not have enough evidence to prove it is effective and roll it 
			out for NHS use.
 
 ChAdOx1 nCoV-19 is made from 
			
			ChAdOx1, a weakened version of the 
			common cold virus (adenovirus) which causes infections in 
			chimpanzees.
 
 The virus has been manipulated so that it cannot harm humans, but 
			also contains part of the Coronavirus so that it would trigger the 
			body's immune response to COVID-19's spike proteins which it uses to 
			enter human cells and multiply.
 
 
 
			  |